Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial

OBJECTIVE: To evaluate the efficacy and safety of adjunctive eslicarbazepine acetate (ESL) in patients with refractory partial-onset seizures. METHODS: This randomized, placebo-controlled, double-blind, parallel-group, phase III study was conducted at 173 centers in 19 countries, including the Unite...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Epilepsia
Main Authors: Sperling, Michael R, Abou-Khalil, Bassel, Harvey, Jay, Rogin, Joanne B, Biraben, Arnaud, Galimberti, Carlo A, Kowacs, Pedro A, Hong, Seung Bong, Cheng, Hailong, Blum, David, Nunes, Teresa, Soares-da-Silva, Patrício
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2015
Assuntos:
Full-Length Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4354260/
https://ncbi.nlm.nih.gov/pubmed/25528898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/epi.12894
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados